Europe Biosimilars Market (2024-2030) | Revenue, Size, Outlook, Forecast, Growth, Analysis, Value, Industry, Trends, Companies & Share

Market Forecast by Countries (Germany, United Kingdom, France, Italy, Russia, Spain, Rest of Europe), By Product (Insulin, Follitropin, Calcitonin, Glucagon, Teriparatide, Others), By Indication (Oncology, Offsite Treatment, Chronic Disorders, Blood Disorders, Infectious Diseases, Others), By Manufacturing (Outsourced, In-house) And Competitive Landscape
Product Code: ETC078266 Publication Date: Aug 2021 Updated Date: Jan 2024 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 200 No. of Figures: 90 No. of Tables: 30

Key Highlights of the Report:

  • Europe Biosimilars Market Outlook
  • Market Size of Europe Biosimilars Market, 2020
  • Forecast of Europe Biosimilars Market, 2030
  • Historical Data and Forecast of Europe Biosimilars Revenues & Volume for the Period 2020 - 2030
  • Europe Biosimilars Market Trend Evolution
  • Europe Biosimilars Market Drivers and Challenges
  • Europe Biosimilars Price Trends
  • Europe Biosimilars Porter's Five Forces
  • Europe Biosimilars Industry Life Cycle
  • Historical Data and Forecast of Europe Biosimilars Market Revenues & Volume By Product for the Period 2020 - 2030
  • Historical Data and Forecast of Europe Biosimilars Market Revenues & Volume By Insulin for the Period 2020 - 2030
  • Historical Data and Forecast of Europe Biosimilars Market Revenues & Volume By Follitropin for the Period 2020 - 2030
  • Historical Data and Forecast of Europe Biosimilars Market Revenues & Volume By Calcitonin for the Period 2020 - 2030
  • Historical Data and Forecast of Europe Biosimilars Market Revenues & Volume By Glucagon for the Period 2020 - 2030
  • Historical Data and Forecast of Europe Biosimilars Market Revenues & Volume By Teriparatide for the Period 2020 - 2030
  • Historical Data and Forecast of Europe Biosimilars Market Revenues & Volume By Others for the Period 2020 - 2030
  • Historical Data and Forecast of Germany Biosimilars Market Revenues & Volume By Product for the Period 2020 - 2030
  • Historical Data and Forecast of Germany Biosimilars Market Revenues & Volume By Insulin for the Period 2020 - 2030
  • Historical Data and Forecast of Germany Biosimilars Market Revenues & Volume By Follitropin for the Period 2020 - 2030
  • Historical Data and Forecast of Germany Biosimilars Market Revenues & Volume By Calcitonin for the Period 2020 - 2030
  • Historical Data and Forecast of Germany Biosimilars Market Revenues & Volume By Glucagon for the Period 2020 - 2030
  • Historical Data and Forecast of Germany Biosimilars Market Revenues & Volume By Teriparatide for the Period 2020 - 2030
  • Historical Data and Forecast of Germany Biosimilars Market Revenues & Volume By Others for the Period 2020 - 2030
  • Historical Data and Forecast of United Kingdom Biosimilars Market Revenues & Volume By Product for the Period 2020 - 2030
  • Historical Data and Forecast of United Kingdom Biosimilars Market Revenues & Volume By Insulin for the Period 2020 - 2030
  • Historical Data and Forecast of United Kingdom Biosimilars Market Revenues & Volume By Follitropin for the Period 2020 - 2030
  • Historical Data and Forecast of United Kingdom Biosimilars Market Revenues & Volume By Calcitonin for the Period 2020 - 2030
  • Historical Data and Forecast of United Kingdom Biosimilars Market Revenues & Volume By Glucagon for the Period 2020 - 2030
  • Historical Data and Forecast of United Kingdom Biosimilars Market Revenues & Volume By Teriparatide for the Period 2020 - 2030
  • Historical Data and Forecast of United Kingdom Biosimilars Market Revenues & Volume By Others for the Period 2020 - 2030
  • Historical Data and Forecast of France Biosimilars Market Revenues & Volume By Product for the Period 2020 - 2030
  • Historical Data and Forecast of France Biosimilars Market Revenues & Volume By Insulin for the Period 2020 - 2030
  • Historical Data and Forecast of France Biosimilars Market Revenues & Volume By Follitropin for the Period 2020 - 2030
  • Historical Data and Forecast of France Biosimilars Market Revenues & Volume By Calcitonin for the Period 2020 - 2030
  • Historical Data and Forecast of France Biosimilars Market Revenues & Volume By Glucagon for the Period 2020 - 2030
  • Historical Data and Forecast of France Biosimilars Market Revenues & Volume By Teriparatide for the Period 2020 - 2030
  • Historical Data and Forecast of France Biosimilars Market Revenues & Volume By Others for the Period 2020 - 2030
  • Historical Data and Forecast of Italy Biosimilars Market Revenues & Volume By Product for the Period 2020 - 2030
  • Historical Data and Forecast of Italy Biosimilars Market Revenues & Volume By Insulin for the Period 2020 - 2030
  • Historical Data and Forecast of Italy Biosimilars Market Revenues & Volume By Follitropin for the Period 2020 - 2030
  • Historical Data and Forecast of Italy Biosimilars Market Revenues & Volume By Calcitonin for the Period 2020 - 2030
  • Historical Data and Forecast of Italy Biosimilars Market Revenues & Volume By Glucagon for the Period 2020 - 2030
  • Historical Data and Forecast of Italy Biosimilars Market Revenues & Volume By Teriparatide for the Period 2020 - 2030
  • Historical Data and Forecast of Italy Biosimilars Market Revenues & Volume By Others for the Period 2020 - 2030
  • Historical Data and Forecast of Russia Biosimilars Market Revenues & Volume By Product for the Period 2020 - 2030
  • Historical Data and Forecast of Russia Biosimilars Market Revenues & Volume By Insulin for the Period 2020 - 2030
  • Historical Data and Forecast of Russia Biosimilars Market Revenues & Volume By Follitropin for the Period 2020 - 2030
  • Historical Data and Forecast of Russia Biosimilars Market Revenues & Volume By Calcitonin for the Period 2020 - 2030
  • Historical Data and Forecast of Russia Biosimilars Market Revenues & Volume By Glucagon for the Period 2020 - 2030
  • Historical Data and Forecast of Russia Biosimilars Market Revenues & Volume By Teriparatide for the Period 2020 - 2030
  • Historical Data and Forecast of Russia Biosimilars Market Revenues & Volume By Others for the Period 2020 - 2030
  • Historical Data and Forecast of Spain Biosimilars Market Revenues & Volume By Product for the Period 2020 - 2030
  • Historical Data and Forecast of Spain Biosimilars Market Revenues & Volume By Insulin for the Period 2020 - 2030
  • Historical Data and Forecast of Spain Biosimilars Market Revenues & Volume By Follitropin for the Period 2020 - 2030
  • Historical Data and Forecast of Spain Biosimilars Market Revenues & Volume By Calcitonin for the Period 2020 - 2030
  • Historical Data and Forecast of Spain Biosimilars Market Revenues & Volume By Glucagon for the Period 2020 - 2030
  • Historical Data and Forecast of Spain Biosimilars Market Revenues & Volume By Teriparatide for the Period 2020 - 2030
  • Historical Data and Forecast of Spain Biosimilars Market Revenues & Volume By Others for the Period 2020 - 2030
  • Historical Data and Forecast of Rest of Europe Biosimilars Market Revenues & Volume By Product for the Period 2020 - 2030
  • Historical Data and Forecast of Rest of Europe Biosimilars Market Revenues & Volume By Insulin for the Period 2020 - 2030
  • Historical Data and Forecast of Rest of Europe Biosimilars Market Revenues & Volume By Follitropin for the Period 2020 - 2030
  • Historical Data and Forecast of Rest of Europe Biosimilars Market Revenues & Volume By Calcitonin for the Period 2020 - 2030
  • Historical Data and Forecast of Rest of Europe Biosimilars Market Revenues & Volume By Glucagon for the Period 2020 - 2030
  • Historical Data and Forecast of Rest of Europe Biosimilars Market Revenues & Volume By Teriparatide for the Period 2020 - 2030
  • Historical Data and Forecast of Rest of Europe Biosimilars Market Revenues & Volume By Others for the Period 2020 - 2030
  • Historical Data and Forecast of Europe Biosimilars Market Revenues & Volume By Indication for the Period 2020 - 2030
  • Historical Data and Forecast of Europe Biosimilars Market Revenues & Volume By Oncology for the Period 2020 - 2030
  • Historical Data and Forecast of Europe Biosimilars Market Revenues & Volume By Offsite Treatment for the Period 2020 - 2030
  • Historical Data and Forecast of Europe Biosimilars Market Revenues & Volume By Chronic Disorders for the Period 2020 - 2030
  • Historical Data and Forecast of Europe Biosimilars Market Revenues & Volume By Blood Disorders for the Period 2020 - 2030
  • Historical Data and Forecast of Europe Biosimilars Market Revenues & Volume By Infectious Diseases for the Period 2020 - 2030
  • Historical Data and Forecast of Europe Biosimilars Market Revenues & Volume By Others for the Period 2020 - 2030
  • Historical Data and Forecast of Germany Biosimilars Market Revenues & Volume By Indication for the Period 2020 - 2030
  • Historical Data and Forecast of Germany Biosimilars Market Revenues & Volume By Oncology for the Period 2020 - 2030
  • Historical Data and Forecast of Germany Biosimilars Market Revenues & Volume By Offsite Treatment for the Period 2020 - 2030
  • Historical Data and Forecast of Germany Biosimilars Market Revenues & Volume By Chronic Disorders for the Period 2020 - 2030
  • Historical Data and Forecast of Germany Biosimilars Market Revenues & Volume By Blood Disorders for the Period 2020 - 2030
  • Historical Data and Forecast of Germany Biosimilars Market Revenues & Volume By Infectious Diseases for the Period 2020 - 2030
  • Historical Data and Forecast of Germany Biosimilars Market Revenues & Volume By Others for the Period 2020 - 2030
  • Historical Data and Forecast of United Kingdom Biosimilars Market Revenues & Volume By Indication for the Period 2020 - 2030
  • Historical Data and Forecast of United Kingdom Biosimilars Market Revenues & Volume By Oncology for the Period 2020 - 2030
  • Historical Data and Forecast of United Kingdom Biosimilars Market Revenues & Volume By Offsite Treatment for the Period 2020 - 2030
  • Historical Data and Forecast of United Kingdom Biosimilars Market Revenues & Volume By Chronic Disorders for the Period 2020 - 2030
  • Historical Data and Forecast of United Kingdom Biosimilars Market Revenues & Volume By Blood Disorders for the Period 2020 - 2030
  • Historical Data and Forecast of United Kingdom Biosimilars Market Revenues & Volume By Infectious Diseases for the Period 2020 - 2030
  • Historical Data and Forecast of United Kingdom Biosimilars Market Revenues & Volume By Others for the Period 2020 - 2030
  • Historical Data and Forecast of France Biosimilars Market Revenues & Volume By Indication for the Period 2020 - 2030
  • Historical Data and Forecast of France Biosimilars Market Revenues & Volume By Oncology for the Period 2020 - 2030
  • Historical Data and Forecast of France Biosimilars Market Revenues & Volume By Offsite Treatment for the Period 2020 - 2030
  • Historical Data and Forecast of France Biosimilars Market Revenues & Volume By Chronic Disorders for the Period 2020 - 2030
  • Historical Data and Forecast of France Biosimilars Market Revenues & Volume By Blood Disorders for the Period 2020 - 2030
  • Historical Data and Forecast of France Biosimilars Market Revenues & Volume By Infectious Diseases for the Period 2020 - 2030
  • Historical Data and Forecast of France Biosimilars Market Revenues & Volume By Others for the Period 2020 - 2030
  • Historical Data and Forecast of Italy Biosimilars Market Revenues & Volume By Indication for the Period 2020 - 2030
  • Historical Data and Forecast of Italy Biosimilars Market Revenues & Volume By Oncology for the Period 2020 - 2030
  • Historical Data and Forecast of Italy Biosimilars Market Revenues & Volume By Offsite Treatment for the Period 2020 - 2030
  • Historical Data and Forecast of Italy Biosimilars Market Revenues & Volume By Chronic Disorders for the Period 2020 - 2030
  • Historical Data and Forecast of Italy Biosimilars Market Revenues & Volume By Blood Disorders for the Period 2020 - 2030
  • Historical Data and Forecast of Italy Biosimilars Market Revenues & Volume By Infectious Diseases for the Period 2020 - 2030
  • Historical Data and Forecast of Italy Biosimilars Market Revenues & Volume By Others for the Period 2020 - 2030
  • Historical Data and Forecast of Russia Biosimilars Market Revenues & Volume By Indication for the Period 2020 - 2030
  • Historical Data and Forecast of Russia Biosimilars Market Revenues & Volume By Oncology for the Period 2020 - 2030
  • Historical Data and Forecast of Russia Biosimilars Market Revenues & Volume By Offsite Treatment for the Period 2020 - 2030
  • Historical Data and Forecast of Russia Biosimilars Market Revenues & Volume By Chronic Disorders for the Period 2020 - 2030
  • Historical Data and Forecast of Russia Biosimilars Market Revenues & Volume By Blood Disorders for the Period 2020 - 2030
  • Historical Data and Forecast of Russia Biosimilars Market Revenues & Volume By Infectious Diseases for the Period 2020 - 2030
  • Historical Data and Forecast of Russia Biosimilars Market Revenues & Volume By Others for the Period 2020 - 2030
  • Historical Data and Forecast of Spain Biosimilars Market Revenues & Volume By Indication for the Period 2020 - 2030
  • Historical Data and Forecast of Spain Biosimilars Market Revenues & Volume By Oncology for the Period 2020 - 2030
  • Historical Data and Forecast of Spain Biosimilars Market Revenues & Volume By Offsite Treatment for the Period 2020 - 2030
  • Historical Data and Forecast of Spain Biosimilars Market Revenues & Volume By Chronic Disorders for the Period 2020 - 2030
  • Historical Data and Forecast of Spain Biosimilars Market Revenues & Volume By Blood Disorders for the Period 2020 - 2030
  • Historical Data and Forecast of Spain Biosimilars Market Revenues & Volume By Infectious Diseases for the Period 2020 - 2030
  • Historical Data and Forecast of Spain Biosimilars Market Revenues & Volume By Others for the Period 2020 - 2030
  • Historical Data and Forecast of Rest of Europe Biosimilars Market Revenues & Volume By Indication for the Period 2020 - 2030
  • Historical Data and Forecast of Rest of Europe Biosimilars Market Revenues & Volume By Oncology for the Period 2020 - 2030
  • Historical Data and Forecast of Rest of Europe Biosimilars Market Revenues & Volume By Offsite Treatment for the Period 2020 - 2030
  • Historical Data and Forecast of Rest of Europe Biosimilars Market Revenues & Volume By Chronic Disorders for the Period 2020 - 2030
  • Historical Data and Forecast of Rest of Europe Biosimilars Market Revenues & Volume By Blood Disorders for the Period 2020 - 2030
  • Historical Data and Forecast of Rest of Europe Biosimilars Market Revenues & Volume By Infectious Diseases for the Period 2020 - 2030
  • Historical Data and Forecast of Rest of Europe Biosimilars Market Revenues & Volume By Others for the Period 2020 - 2030
  • Historical Data and Forecast of Europe Biosimilars Market Revenues & Volume By Manufacturing for the Period 2020 - 2030
  • Historical Data and Forecast of Europe Biosimilars Market Revenues & Volume By Outsourced for the Period 2020 - 2030
  • Historical Data and Forecast of Europe Biosimilars Market Revenues & Volume By In-house for the Period 2020 - 2030
  • Historical Data and Forecast of Germany Biosimilars Market Revenues & Volume By Manufacturing for the Period 2020 - 2030
  • Historical Data and Forecast of Germany Biosimilars Market Revenues & Volume By Outsourced for the Period 2020 - 2030
  • Historical Data and Forecast of Germany Biosimilars Market Revenues & Volume By In-house for the Period 2020 - 2030
  • Historical Data and Forecast of United Kingdom Biosimilars Market Revenues & Volume By Manufacturing for the Period 2020 - 2030
  • Historical Data and Forecast of United Kingdom Biosimilars Market Revenues & Volume By Outsourced for the Period 2020 - 2030
  • Historical Data and Forecast of United Kingdom Biosimilars Market Revenues & Volume By In-house for the Period 2020 - 2030
  • Historical Data and Forecast of France Biosimilars Market Revenues & Volume By Manufacturing for the Period 2020 - 2030
  • Historical Data and Forecast of France Biosimilars Market Revenues & Volume By Outsourced for the Period 2020 - 2030
  • Historical Data and Forecast of France Biosimilars Market Revenues & Volume By In-house for the Period 2020 - 2030
  • Historical Data and Forecast of Italy Biosimilars Market Revenues & Volume By Manufacturing for the Period 2020 - 2030
  • Historical Data and Forecast of Italy Biosimilars Market Revenues & Volume By Outsourced for the Period 2020 - 2030
  • Historical Data and Forecast of Italy Biosimilars Market Revenues & Volume By In-house for the Period 2020 - 2030
  • Historical Data and Forecast of Russia Biosimilars Market Revenues & Volume By Manufacturing for the Period 2020 - 2030
  • Historical Data and Forecast of Russia Biosimilars Market Revenues & Volume By Outsourced for the Period 2020 - 2030
  • Historical Data and Forecast of Russia Biosimilars Market Revenues & Volume By In-house for the Period 2020 - 2030
  • Historical Data and Forecast of Spain Biosimilars Market Revenues & Volume By Manufacturing for the Period 2020 - 2030
  • Historical Data and Forecast of Spain Biosimilars Market Revenues & Volume By Outsourced for the Period 2020 - 2030
  • Historical Data and Forecast of Spain Biosimilars Market Revenues & Volume By In-house for the Period 2020 - 2030
  • Historical Data and Forecast of Rest of Europe Biosimilars Market Revenues & Volume By Manufacturing for the Period 2020 - 2030
  • Historical Data and Forecast of Rest of Europe Biosimilars Market Revenues & Volume By Outsourced for the Period 2020 - 2030
  • Historical Data and Forecast of Rest of Europe Biosimilars Market Revenues & Volume By In-house for the Period 2020 - 2030
  • Europe Biosimilars Market - Key Performance Indicators
  • Europe Biosimilars Market - Import Export Trade Statistics
  • Europe Biosimilars Market - Opportunity Assessment By Countries
  • Europe Biosimilars Market - Opportunity Assessment By Product
  • Europe Biosimilars Market - Opportunity Assessment By Indication
  • Europe Biosimilars Market - Opportunity Assessment By Manufacturing
  • Europe Biosimilars Market - Top Companies Market Share
  • Europe Biosimilars Market - Top Companies Profiles
  • Europe Biosimilars Market - Comparison of Players in Technical and Operating Parameters
  • Europe Biosimilars Market - Strategic Recommendations
Frequently Asked Questions About the Market Study (FAQs):
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Europe Biosimilars Market Overview

3.1 Europe Regional Macro Economic Indicators

3.2 Europe Biosimilars Market Revenues & Volume, 2020 & 2030F

3.3 Europe Biosimilars Market - Industry Life Cycle

3.4 Europe Biosimilars Market - Porter's Five Forces

3.5 Europe Biosimilars Market Revenues & Volume Share, By Countries, 2020 & 2030F

3.6 Europe Biosimilars Market Revenues & Volume Share, By Form, 2020 & 2030F

3.7 Europe Biosimilars Market Revenues & Volume Share, By Indication, 2020 & 2030F

3.8 Europe Biosimilars Market Revenues & Volume Share, By Manufacturing, 2020 & 2030F

4 Europe Biosimilars Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 Europe Biosimilars Market Trends

6 Europe Biosimilars Market, 2020 - 2030

6.1 Europe Biosimilars Market, Revenues & Volume, By Product, 2020 - 2030

6.2 Europe Biosimilars Market, Revenues & Volume, By Indication, 2020 - 2030

6.3 Europe Biosimilars Market, Revenues & Volume, By Manufacturing, 2020 - 2030

7 Germany Biosimilars Market, 2020 - 2030

7.1 Germany Biosimilars Market, Revenues & Volume, By Product, 2020 - 2030

7.2 Germany Biosimilars Market, Revenues & Volume, By Indication, 2020 - 2030

7.3 Germany Biosimilars Market, Revenues & Volume, By Manufacturing, 2020 - 2030

8 United Kingdom Biosimilars Market, 2020 - 2030

8.1 United Kingdom Biosimilars Market, Revenues & Volume, By Product, 2020 - 2030

8.2 United Kingdom Biosimilars Market, Revenues & Volume, By Indication, 2020 - 2030

8.3 United Kingdom Biosimilars Market, Revenues & Volume, By Manufacturing, 2020 - 2030

9 France Biosimilars Market, 2020 - 2030

9.1 France Biosimilars Market, Revenues & Volume, By Product, 2020 - 2030

9.2 France Biosimilars Market, Revenues & Volume, By Indication, 2020 - 2030

9.3 France Biosimilars Market, Revenues & Volume, By Manufacturing, 2020 - 2030

10 Italy Biosimilars Market, 2020 - 2030

10.1 Italy Biosimilars Market, Revenues & Volume, By Product, 2020 - 2030

10.2 Italy Biosimilars Market, Revenues & Volume, By Indication, 2020 - 2030

10.3 Italy Biosimilars Market, Revenues & Volume, By Manufacturing, 2020 - 2030

11 Russia Biosimilars Market, 2020 - 2030

11.1 Russia Biosimilars Market, Revenues & Volume, By Product, 2020 - 2030

11.2 Russia Biosimilars Market, Revenues & Volume, By Indication, 2020 - 2030

11.3 Russia Biosimilars Market, Revenues & Volume, By Manufacturing, 2020 - 2030

12 Spain Biosimilars Market, 2020 - 2030

12.1 Spain Biosimilars Market, Revenues & Volume, By Product, 2020 - 2030

12.2 Spain Biosimilars Market, Revenues & Volume, By Indication, 2020 - 2030

12.3 Spain Biosimilars Market, Revenues & Volume, By Manufacturing, 2020 - 2030

13 Rest of Europe Biosimilars Market, 2020 - 2030

13.1 Rest of Europe Biosimilars Market, Revenues & Volume, By Product, 2020 - 2030

13.2 Rest of Europe Biosimilars Market, Revenues & Volume, By Indication, 2020 - 2030

13.3 Rest of Europe Biosimilars Market, Revenues & Volume, By Manufacturing, 2020 - 2030

14 Europe Biosimilars Market Key Performance Indicators

15 Europe Biosimilars Market - Opportunity Assessment

15.1 Europe Biosimilars Market Opportunity Assessment, By Countries, 2020 & 2030F

15.2 Europe Biosimilars Market Opportunity Assessment, By Product, 2020 & 2030F

15.3 Europe Biosimilars Market Opportunity Assessment, By Indication, 2020 & 2030F

15.4 Europe Biosimilars Market Opportunity Assessment, By Manufacturing, 2020 & 2030F

16 Europe Biosimilars Market - Competitive Landscape

16.1 Europe Biosimilars Market Revenue Share, By Companies, 2020

16.2 Europe Biosimilars Market Competitive Benchmarking, By Operating and Technical Parameters

17 Company Profiles

18 Recommendations

19 Disclaimer

Pricing
  • Single User License
    $ 4,560
  • Department License
    $ 5,055
  • Site License
    $ 5,595
  • Global License
    $ 6,000
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Related Reports

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All